Straits Times Index
3,101.93 +9.82 (+0.32%) Nikkei
28,029.57 +276.20 (+1.00%) Hang Seng
23,766.69 -22.24 (-0.09%) FTSE 100
7,122.32 -6.89 (-0.10%) BTC-USD
49,236.03 -4,425.06 (-8.25%) CMC Crypto 200
1,367.14 -74.62 (-5.18%)
DBS CEO says tough for digital banks to muscle into Singapore
LifeStance Health Group, Inc. (LFST)
After hours:
| Previous close | 8.92 |
| Open | 8.90 |
| Bid | 8.43 x 800 |
| Ask | 8.74 x 1300 |
| Day's range | 8.29 - 8.94 |
| 52-week range | 7.64 - 29.81 |
| Volume | |
| Avg. volume | 1,190,852 |
| Market cap | 3.244B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.33 |
- Business Wire
LIFESTANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeStance Health Group, Inc. on Behalf of LifeStance Stockholders and Encourages Investors to Contact the Firm
NEW YORK, November 18, 2021--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against LifeStance Health Group ("LifeStance" or the "Company") (NASDAQ: LFST) on behalf of LifeStance stockholders. Our investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices.
- Business Wire
INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of LifeStance Health Group, Inc. (LFST) Investors
NEW YORK, November 11, 2021--The law firm of Kirby McInerney LLP is investigating potential claims against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST). The investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices.
- Business Wire
LFST INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into LifeStance Health Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact Firm
SAN DIEGO, November 10, 2021--Robbins Geller Rudman & Dowd LLP announces an investigation into potential violations of U.S. federal securities laws by LifeStance Health Group, Inc. (NASDAQ: LFST) focused on whether LifeStance Health and certain of its officers and directors, as well as the underwriters of LifeStance Health’s June 2021 initial public offering, made false and misleading statements and/or failed to disclose material information to investors.
